London Regional Cancer Program

Fall 2017 Catalyst Grants for Translational Research Competition Awardees

Please join me in congratulating the successful applicants:

Dr. Samuel Asfaha

Title:

Stem cell markers in metastasis.

Amount Funded:

$25,000 (Translational Metastasis Cancer Research focus)

   

Dr. Muriel Brackstone

Title:

Oncoplastic breast cancer surgery in Ontario.

Amount Funded: $30,000 (Division of Surgical Oncology Award)
   

Dr. Rodney DeKoter

Title:

Identification and characterization of driver mutations in precursor B cell acute lymphoblastic leukemia.

Amount Funded: $22,500 (Translational Leukemia Cancer Research focus)
   

Dr. Jonathan Izawa, Co-Applicants: Drs. Bekim Sadikovic, Khalil Hetou, Erfan Aref-Esghgi

Title:

Development of diagnostic and prognostic epigenomic tools in prostate cancer.

Amount Funded: $25,000 (Translational Prostate Cancer Research focus)
   

Dr. Richard Kim

Title:

Personalizing aromatase inhibitor therapy for breast cancer patients.

Amount Funded: $24,982.50 (Translational Breast Cancer Research focus)
   

Dr. Peeyush Lala, Co-Applicants: Drs. Ted Vandenberg, David Hess

Title:

Validation of EP4 as a therapeutic target in triple negative human breast cancer.

Amount Funded: $25,000 (Translational Breast Cancer Research focus)
   

Dr. Len Luyt, Co-Applicant: Dr. Eva Turley

Title:

The development of drugs interfering with RHAMM-hyaluronan interactions as a novel targeted therapy for aggressive prostate cancer.

Amount

Funded:

$25,000 (Translational Prostate Cancer Research focus)
   

 Dr. Danielle MacNeil, Co-Applicants:  Dr. Amit Garg, 

 Anthony Nichols, Kevin Fung, John Yoo

Title:

Geographic disparities head and neck cancer.

Amount Funded: $29,468 (Division of Surgical Oncology Award)
   

 Dr. Anthony Nichols, Co-Applicant: Dr. Shawn Li

Title:

Informing targeted therapy and immune therapy for HNSCC by functional proteomics.

Amount Funded: $30,000 (Division of Surgical Oncology Award)
   

 Dr. Trevor Shepherd, Co-Applicant: Dr. James Petrik

Title:

Evaluation of dysregulated Mevalonate pathway activity in mutant p53 precursor lesions of ovarian high-grade serous cancer.

Amount Funded: $25,000 (Translational Ovarian Cancer Research focus)

 

Congratulations and well done!

Joe Mymryk, PhD

Chair, Grant Review Panel

LRCP Catalyst Grants for Translational Cancer Research and Training